Peptidyl derivatives as proteasome inhibitors

被引：0
|
作者：
Wójcik, C [1 ]
机构：
[1] Med Acad Warsaw, Inst Biostruct, Dept Histol & Embryol, PL-02004 Warsaw, Poland
来源：
DRUG DISCOVERY TODAY | 1999年 / 4卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：189 / 190
页数：2
相关论文
共 50 条
  • [41] Structure of the Mycobacterium tuberculosis proteasome and mechanism of inhibition by a peptidyl boronate
    Hu, GQ
    Lin, G
    Wang, M
    Dick, L
    Xu, RM
    Nathan, C
    Li, HL
    MOLECULAR MICROBIOLOGY, 2006, 59 (05) : 1417 - 1428
  • [42] The ubiquitin-proteasome pathway and proteasome inhibitors
    Myung, J
    Kim, KB
    Crews, CM
    MEDICINAL RESEARCH REVIEWS, 2001, 21 (04) : 245 - 273
  • [43] Peptidyl-prolyl isomerase inhibitors
    Wang, XDJ
    Etzkorn, FA
    BIOPOLYMERS, 2006, 84 (02) : 125 - 146
  • [44] Proteasome inhibitors as therapeutics
    Mitsiades, CS
    Mitsiades, N
    Hideshima, T
    Richardson, PG
    Anderson, KC
    ESSAYS IN BIOCHEMISTRY, VOL 41: THE UBIQUITIN-PROTEASOME SYSTEM, 2005, 41 : 205 - 218
  • [45] Farnesyl transferase inhibitors and proteasome inhibitors
    Johnston, SRD
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S87 - S87
  • [46] POTENT INHIBITORS OF PROTEASOME
    IQBAL, M
    CHATTERJEE, S
    KAUER, JC
    DAS, M
    MESSINA, P
    FREED, B
    BIAZZO, W
    SIMAN, R
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (13) : 2276 - 2277
  • [47] Are proteasome inhibitors a panacea?
    Wójcik, C
    DRUG DISCOVERY TODAY, 1999, 4 (04) : 192 - 192
  • [48] Macrocyclic Proteasome Inhibitors
    Krahn, D.
    Ottmann, C.
    Kaiser, M.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (33) : 5052 - 5060
  • [49] New Proteasome Inhibitors
    Orlowski, Robert Z.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S43 - S44
  • [50] Proteasome inhibitors Commentary
    Teicher, Beverly A.
    Tomaszewski, Joseph E.
    BIOCHEMICAL PHARMACOLOGY, 2015, 96 (01) : 1 - 9
12345